Status:
COMPLETED
Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Breast Cancer Screening
Eligibility:
FEMALE
30+ years
Brief Summary
Breast tumors are often detected on mammography but may be harder to see in women with dense breasts. This is why screening breast ultrasound is sometimes used as another test in women with dense brea...
Eligibility Criteria
Inclusion
- Women scheduled for screening WBUS and a screening FFDM on the same day or within the following 30 days of each other
- Women scheduled for screening CEDM alone
- Women scheduled for WBUS and screening CEDM on the same day or within 30 days of one another
Exclusion
- Age \< 30 years old
- Male patients
- Patients with any clinical breast symptoms (palpable mass, nipple discharge, etc)
- Patients with known diagnosis of breast cancer
- Patients with any breast surgery or biopsy within 90 days prior to the study
- Patients who have had a lumpectomy for breast cancer within 18 months prior to the study
- Patients who are thought to have a breast MRI within 1 year prior to the study
- Patients with contraindication to the intravenous use of iodinated contrast agent (i.e. allergy to iodinated contrast or severely impaired renal function with a creatinine level ≥1.3)
Key Trial Info
Start Date :
December 2 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 26 2025
Estimated Enrollment :
487 Patients enrolled
Trial Details
Trial ID
NCT02310698
Start Date
December 2 2014
End Date
March 26 2025
Last Update
March 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065